MD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
487.8M
+2.4%
476.2M
-3.6%
493.8M
+0.2%
492.9M
+5.1%
468.8M
Cost of Revenue
0
0
0
0
0
Gross Profit
487.8M
+2.4%
476.2M
-3.6%
493.8M
+0.2%
492.9M
+5.1%
468.8M
Operating Expenses
430.9M
-0.8%
434.5M
-2.3%
445.0M
+4.7%
424.8M
+3.9%
409.0M
R&D
0
0
0
0
0
SG&A
397.4M
-2.1%
406.0M
-71.1%
1.4B
+2213.7%
60.8M
-84.0%
379.2M
Operating Income
56.9M
+36.6%
41.7M
-14.6%
48.8M
-28.3%
68.1M
+13.7%
59.9M
EBITDA
71.2M
+35.1%
52.7M
-12.6%
60.3M
-24.2%
79.6M
+15.3%
69.0M
Net Income
39.8M
+34.7%
29.6M
-12.2%
33.7M
-53.0%
71.7M
+82.6%
39.3M
EPS (Basic)
$0.50
+35.1%
$0.37
-9.8%
$0.41
-51.8%
$0.85
+84.8%
$0.46
EPS (Diluted)
$0.49
+36.1%
$0.36
-10.0%
$0.40
-52.4%
$0.84
+82.6%
$0.46
Shares (Diluted)
81.4M
-2.0%
83.1M
-1.7%
84.5M
-1.3%
85.6M
+0.1%
85.5M
Pediatrix Medical (MD) โ€” Financials